Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| VERU INC.VERU · Entity 7234 | Chief Scientific Officer | May 02, 2018 | May 04, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
VERU INC.
Report date May 02, 2018 · Filed May 04, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $1.89 · Expires 2028-05-02 | Direct | 99,000 |
Reported balance
After 2018-05-02 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2018-05-02 · Grant · Acquired 99,000 · Balance 99,000 F1: Options for one-third of the shares vest on each of May 2, 2019, May 2, 2020 and May 2, 2021. |
Filing footnotes · ownership attribution and instrument terms
F1: Options for one-third of the shares vest on each of May 2, 2019, May 2, 2020 and May 2, 2021.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 02, 2018 Filed May 4, 2018 15:20 UTC | VERU INC. VERU · Entity 7234 | GrantCommon Stock Option · Derivative | 99,000 | $0.00 Strike: $1.89 | $0.00 |
DisclosureSEC source: 0001042167-18-000050 · primary_doc.xml · derivative · entry 1 Getzenberg Robert · CIK 0001735553 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,000 Underlying: Common Stock · 99,000 shares Expires 2028-05-02 F1 · derivative.exercise_date: Options for one-third of the shares vest on each of May 2, 2019, May 2, 2020 and May 2, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.